Senate Health & Welfare hears H.482 after UVM Health Network–Blue Cross settlement; witnesses warn of insurer, hospital solvency risks
Loading...
Summary
On April 17, the Senate Health & Welfare Committee heard testimony on H.482, a bill that would give the Green Mountain Care Board statutory authority to intervene in hospital budgeting and commercial reimbursement under specified triggers.
On April 17, the Senate Health & Welfare Committee heard testimony on H.482, a bill that would give the Green Mountain Care Board statutory authority to intervene in hospital budgeting and commercial reimbursement under specified triggers. Witnesses described a recent negotiated agreement between UVM Health Network and Blue Cross Blue Shield of Vermont and warned that both insurer and hospital financial stress could threaten access and affordability.
Committee members said the panel’s purpose was to determine whether statutory "guardrails" are needed after the November dispute that preceded the settlement. Senator Ginny Lyons, a member of the committee, opened the session and invited testimony.
Steve Leffler, president of UVM Medical Center, said the network and the Green Mountain Care Board reached an agreement after months of meetings and that the parties had committed to specific short-term measures. "In November, the network made some mistakes," Leffler said, adding that the agreement included $11,000,000 in funding for non‑UVM primary‑care providers across the state and a $12,000,000 payment to Blue Cross to resolve earlier disputes. He said the settlement also imposes budget guidance limiting revenue growth to about 3.4%, caps commercial rate increases to roughly 3% for some entities, and constrains expense growth to 3% for 2026 budgeting.
Leffler described efforts to expand access and stabilize primary care within the network, including optimizing schedules and e‑consult services. "We've done more than 2,000 of them this year," he said of e‑consults that he said free up specialty appointments and are filled within 36 hours most of the time.
Leffler emphasized hospitals' sensitivity to balance‑sheet measures. He provided the committee with recent days‑cash‑on‑hand figures, saying the network had about 143 days cash on hand at the end of fiscal year 2024 and the medical center about 134 days; by February those figures had declined (he said the medical center had 118 days at that point). "Days cash on hand is really our balance sheet. It's our savings," Leffler said, adding that more than 60% of hospital expense is labor and that sudden declines in cash reserves can affect bond covenants and borrowing costs.
Mike Fisher, a health care advocate, urged urgency in the committee’s work and warned repeatedly that insurer failure would have catastrophic effects. "I don't believe the other carrier stays in the market," Fisher said when describing the hypothetical collapse of Blue Cross and the knock‑on effects for the qualified health plan market, employers and hospitals. Fisher recommended using a different solvency trigger than days cash on hand, suggesting measures such as unrestricted net assets as a potential alternative for defining insolvency triggers.
Ben Foster, chair of the Green Mountain Care Board, told the panel the bill’s authority to appoint an overseer would apply only under specific triggers, including findings of credible misrepresentations to state authorities in budget submissions or significant budget noncompliance. "We cannot tolerate that," Foster said, describing past board findings of credibility and accuracy issues in some financial submissions. Foster argued the bill ties insurer and hospital solvency concerns together and said a 135‑day days‑cash threshold (or the bill's equivalent) would currently apply to only a small number of hospitals.
Committee members pressed witnesses on several points: whether added oversight would interfere with local hospital boards, how the proposed triggers would apply consistently across hospitals and networks, and what the potential effect on bond covenants and borrowing would be if the board imposed midyear changes. Witnesses repeatedly requested that their testimony documents be posted for the record; the committee chair acknowledged that testimony would be submitted to staff for posting.
The hearing did not include a formal vote. Senators signaled they expect to revisit H.482 at a subsequent meeting; the chair said the bill will return for further consideration next week (date not specified at the hearing). Witnesses asked for additional time for the work group created under the settlement to complete a 16‑month review before permanent statutory changes are enacted, while regulators urged balanced statutory authority given the present market instability.
The committee moved to a short recess after the testimony and planned to take up another bill when it reconvened.

